Biotechnology & Pharmaceuticals Industry |
1 Q |
4 Q |
3 Q |
2 Q |
1 Q |
|
Q1 2025 |
FY 2024 and Q4 2024 |
Q3 2024 |
Q2 2024 |
Q1 2024 |
Y / Y Revenue Quarterly Growth |
11.96 % |
-2.05 % |
13.5 % |
12.11 % |
-1.28 % |
Sequential Revenue Quarterly Growth |
-9.83 % |
0.17 % |
9.64 % |
12.35 % |
-21 % |
Revenue Growth Overall Ranking Y/Y |
# 11 |
# 75 |
# 13 |
# 11 |
# 62 |
Y / Y Revenue Annual Growth (at the end of Fiscal Year) |
|
5.11 % |
|
|
|
Y / Y Revenue Growth (12 Months at Quarter Ending) |
5.32 % |
5.11 % |
5.4 % |
-0.54 % |
-7.13 % |
Sequential Revenue Growth (12 Months at Quarter Ending) |
2.5 % |
-0.69 % |
3.21 % |
2.74 % |
-0.36 % |
Revenue Growth Ranking Y/Y (TTM) |
# 46 |
# 43 |
# 40 |
# 58 |
# 81 |
Y / Y Operating Income Quarterly Growth |
- |
34.86 % |
331.4 % |
129.77 % |
- |
Sequential Operating Income Quarterly Growth |
3.08 % |
62.8 % |
-27.52 % |
- |
- |
Operating Income Overall Ranking Y/Y |
# 11 |
# 75 |
# 14 |
# 10 |
# 62 |
Y / Y Operating Income Annual Growth (at the end of Fiscal Year) |
- |
-71.9 % |
|
- |
- |
Y / Y Operating Income Growth (12 Months trailing by quarter ending) |
- |
-71.9 % |
-91.61 % |
- |
- |
Sequential Operating Income Growth (12 Months trailing by quarter ending) |
- |
46.28 % |
- |
- |
- |
Operating Income Growth Ranking Y/Y (TTM) |
# 46 |
# 43 |
# 40 |
# 58 |
# 81 |
Y / Y Income from Cont. Ops Quarterly Growth |
- |
-75.33 % |
- |
- |
- |
Sequential Income from Cont. Ops Quarterly Growth |
- |
-86.45 % |
383.5 % |
- |
- |
Income from Cont. Ops Overall Ranking Y/Y |
# 11 |
# 75 |
# 14 |
# 10 |
# 62 |
Y / Y Income from Cont. Ops Annual Growth (at the end of Fiscal Year) |
- |
- |
- |
- |
- |
Y / Y Income from Cont. Ops Growth (12 Months trailing by quarter ending) |
- |
- |
- |
- |
- |
Sequential Income from Cont. Ops Growth (12 Months trailing by quarter ending) |
- |
- |
- |
- |
- |
Income from Cont. Ops Growth Ranking Y/Y (TTM) |
# 46 |
# 43 |
# 40 |
# 58 |
# 81 |
Y / Y Net Income Quarterly Growth |
- |
-75.08 % |
- |
- |
- |
Sequential Net Income Quarterly Growth |
- |
-86.45 % |
383.36 % |
- |
- |
Net Income Overall Ranking Y/Y |
# 11 |
# 75 |
# 14 |
# 10 |
# 62 |
Y / Y Net Income Annual Growth (at the end of Fiscal Year) |
- |
- |
- |
- |
- |
Y / Y Net Income Growth (12 Months trailing by quarter ending) |
- |
- |
- |
- |
- |
Sequential Net Income Growth (12 Months trailing by quarter ending) |
- |
- |
- |
- |
- |
Net Income Growth Ranking Y/Y (TTM) |
# 46 |
# 43 |
# 40 |
# 58 |
# 81 |
Y / Y Free Cash Flow Quarterly Growth |
- |
252.94 % |
168.78 % |
-45.2 % |
1849.97 % |
Sequential Free Cash Flow Quarterly Growth |
- |
38.66 % |
142.7 % |
104.04 % |
-51.44 % |
Free Cash Flow Overall Ranking Y/Y |
# 11 |
# 75 |
# 14 |
# 10 |
# 62 |
Y / Y Free Cash Flow Annual Growth (at the end of Fiscal Year) |
|
71.29 % |
|
|
|
Y / Y Free Cash Flow Growth (12 Months trailing by quarter ending) |
76.76 % |
71.29 % |
0.77 % |
-38.43 % |
-38.11 % |
Sequential Free Cash Flow Growth (12 Months trailing by quarter ending) |
-9.99 % |
41.12 % |
33 % |
-14.6 % |
6.42 % |
Free Cash Flow Growth Ranking Y/Y (TTM) |
# 46 |
# 43 |
# 40 |
# 58 |
# 81 |
Y / Y Capital Expenditures Quarterly Growth |
-29.54 % |
34.67 % |
3.71 % |
-22.2 % |
-8.44 % |
Sequential Capital Expenditures Quarterly Growth |
-57.24 % |
54.93 % |
5.61 % |
-7.85 % |
-11.9 % |
Capital Expenditures Overall Ranking Y/Y |
# 11 |
# 75 |
# 14 |
# 10 |
# 62 |
Y / Y Capital Expenditures Annual Growth (at the end of Fiscal Year) |
|
3.5 % |
|
|
|
Y / Y Capital Expenditures Growth (12 Months trailing by quarter ending) |
-1.81 % |
3.5 % |
5.33 % |
7.72 % |
14.14 % |
Sequential Capital Expenditures Growth (12 Months trailing by quarter ending) |
-7.09 % |
10.94 % |
0.36 % |
-4.77 % |
-2.33 % |
Capital Expenditures Growth Ranking Y/Y (TTM) |
# 46 |
# 43 |
# 40 |
# 58 |
# 81 |